Hiroshi Kimura
#171,219
Most Influential Person Now
Researcher ORCID: 0000-0001-8063-5660
Hiroshi Kimura's AcademicInfluence.com Rankings
Hiroshi Kimuracomputer-science Degrees
Computer Science
#10490
World Rank
#11020
Historical Rank
Computational Linguistics
#2646
World Rank
#2673
Historical Rank
Machine Learning
#4794
World Rank
#4849
Historical Rank
Artificial Intelligence
#5160
World Rank
#5228
Historical Rank
Download Badge
Computer Science
Hiroshi Kimura's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science Kyoto University
- Bachelors Computer Science Kyoto University
Similar Degrees You Can Earn
Why Is Hiroshi Kimura Influential?
(Suggest an Edit or Addition)Hiroshi Kimura's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay (1999) (575)
- Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. (2011) (505)
- Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. (2001) (401)
- EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. (2012) (344)
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022) (293)
- Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. (2009) (260)
- Proposed guidelines for diagnosing chronic active Epstein‐Barr virus infection (2005) (250)
- Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD (2008) (222)
- Prognostic factors for chronic active Epstein-Barr virus infection. (2003) (205)
- Quantitative analysis of cytomegalovirus load using a real‐time PCR assay (2000) (193)
- Pathogenesis of chronic active Epstein‐Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? (2006) (168)
- Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. (2001) (166)
- Detection of influenza virus RNA by reverse transcription‐PCR and proinflammatory cytokines in influenza‐virus‐associated encephalopathy (1999) (163)
- Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. (1991) (157)
- Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV‐associated disease (2008) (149)
- Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. (2004) (142)
- Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases (1995) (134)
- Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. (2000) (133)
- Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. (2009) (131)
- Human herpesvirus-6 DNA in cerebrospinal fluid of a child with exanthem subitum and meningoencephalitis. (1992) (129)
- Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. (2005) (124)
- Systemic cytokine responses in patients with influenza-associated encephalopathy. (2003) (123)
- Characterization of mast cell-committed progenitors present in human umbilical cord blood. (1999) (119)
- Chronic Active Epstein–Barr Virus Disease (2017) (113)
- Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. (2003) (110)
- Defective Epstein–Barr virus in chronic active infection and haematological malignancy (2019) (110)
- Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. (1996) (108)
- Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. (2009) (107)
- Simultaneous Quantification of Epstein-Barr Virus, Cytomegalovirus, and Human Herpesvirus 6 DNA in Samples from Transplant Recipients by Multiplex Real-Time PCR Assay (2007) (105)
- Rapid Determination of Epstein-Barr Virus–Specific CD8+T-Cell Frequencies by Flow Cytometry (1999) (103)
- Relapse of herpes simplex encephalitis in children. (1992) (101)
- Monitoring four herpesviruses in unrelated cord blood transplantation (2000) (99)
- Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. (1994) (84)
- Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type (2012) (83)
- The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. (1991) (82)
- Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. (1999) (80)
- Establishment of anti‐Epstein–Barr virus (EBV) cellular immunity by adoptive transfer of virus‐specific cytotoxic T lymphocytes from an HLA‐matched sibling to a patient with severe chronic active EBV infection (1996) (79)
- Epstein-Barr Virus Type 2 Latently Infects T Cells, Inducing an Atypical Activation Characterized by Expression of Lymphotactic Cytokines (2014) (77)
- Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2 (2002) (75)
- Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. (2001) (75)
- Current research on chronic active Epstein–Barr virus infection in Japan (2014) (73)
- Serum amyloid A protein in acute viral infections. (1993) (72)
- Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2 (1991) (71)
- Prospective monitoring of the Epstein–Barr virus DNA by a real‐time quantitative polymerase chain reaction after allogenic stem cell transplantation (2001) (71)
- Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. (2004) (69)
- Herpes Simplex Virus Type 1 UL51 Protein Is Involved in Maturation and Egress of Virus Particles (2005) (69)
- Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. (2008) (68)
- Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. (2009) (67)
- Quantitative analysis of herpes simplex virus DNA in cerebrospinal fluid of children with herpes simplex encephalitis (1993) (66)
- Modes of infection and oncogenesis by the Epstein–Barr virus (2014) (65)
- Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus. (2007) (60)
- Prognostic Factors in Influenza-associated Encephalopathy (2008) (60)
- Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. (2013) (60)
- Ganciclovir Therapy for Congenital Cytomegalovirus Infection in Six Infants (2005) (56)
- Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza (2011) (56)
- One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. (2008) (54)
- SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. (2001) (54)
- Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin. (2006) (53)
- Rapid determination of Epstein-Barr virus-specific CD8(+) T-cell frequencies by flow cytometry. (1999) (51)
- Herpes Simplex Virus Requires Poly(ADP-Ribose) Polymerase Activity for Efficient Replication and Induces Extracellular Signal-Related Kinase-Dependent Phosphorylation and ICP0-Dependent Nuclear Localization of Tankyrase 1 (2011) (51)
- EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment (2019) (51)
- Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. (2015) (51)
- Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. (2006) (49)
- Increased levels of cytokines and high-mobility group box 1 are associated with the development of severe pneumonia, but not acute encephalopathy, in 2009 H1N1 influenza-infected children. (2011) (48)
- Pharmacokinetics and Effects of Ribavirin following Intraventricular Administration for Treatment of Subacute Sclerosing Panencephalitis (2004) (48)
- Detection of Herpesvirus DNA in the Serum of Immunocompetent Children (2002) (48)
- Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH. (2010) (46)
- Clinicopathological analysis of the age‐related differences in patients with Epstein–Barr virus (EBV)‐associated extranasal natural killer (NK)/T‐cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection‐associated lymphoproliferative disorde (2011) (46)
- Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. (1997) (46)
- Impaired cytotoxic T lymphocyte response to Epstein‐Barr virus‐infected NK cells in patients with severe chronic active EBV infection (2001) (46)
- Suppression of Sproutys Has a Therapeutic Effect for a Mouse Model of Ischemia by Enhancing Angiogenesis (2009) (45)
- Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis. (1998) (45)
- T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma (2012) (44)
- Herpes Simplex Virus Type 2 UL56 Interacts with the Ubiquitin Ligase Nedd4 and Increases Its Ubiquitination (2008) (44)
- EBV in T-/NK-Cell Tumorigenesis. (2018) (43)
- Monitoring herpesviruses DNA in three cases of acute retinal necrosis by real-time PCR (2004) (43)
- Transmission of cytomegalovirus via breast milk in extremely premature infants (2011) (42)
- mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells (2014) (42)
- Usefulness of quantitative real‐time polymerase chain reaction in following up patients with Epstein–Barr virus infection after liver transplantation (2000) (42)
- A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features (2017) (41)
- Multiplex real‐time PCR for the simultaneous detection of herpes simplex virus, human herpesvirus 6, and human herpesvirus 7 (2009) (41)
- Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein‐Barr virus infection (2011) (41)
- Early intervention in post-transplant lymphoproliferative disorders based on Epstein–Barr viral load (2000) (41)
- Drug‐Induced Hypersensitivity Syndrome due to Mexiletine Associated with Human Herpes Virus 6 and Cytomegalovirus Reactivation (2005) (41)
- Comparison of the levels of human herpesvirus 6 (HHV‐6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV‐6 encephalopathy (2010) (40)
- Rapid detection of Epstein-Barr virus DNA by loop-mediated isothermal amplification method. (2006) (40)
- Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection (2000) (40)
- Hemiconvulsion–hemiplegia syndrome and primary human herpesvirus 7 infection (2004) (39)
- Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan (2014) (38)
- Isolation and Characterization of Mini-Tn5Km2 Insertion Mutants of Enterohemorrhagic Escherichia coli O157:H7 Deficient in Adherence to Caco-2 Cells (2000) (37)
- Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder. (2000) (36)
- Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads. (2010) (36)
- Different Distributions of Epstein-Barr Virus Early and Late Gene Transcripts within Viral Replication Compartments (2013) (36)
- Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma (2013) (35)
- Epstein-Barr virus infection-induced inflammasome activation in human monocytes (2017) (35)
- Prevalence of Maternal Cytomegalovirus (CMV) Antibody and Detection of CMV DNA in Amniotic Fluid (1999) (35)
- Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte–macrophage colony‐stimulating factor for murine ovarian cancer (2014) (35)
- Pin1 Interacts with the Epstein-Barr Virus DNA Polymerase Catalytic Subunit and Regulates Viral DNA Replication (2012) (35)
- Comparison of Real‐Time and Nested PCR Assays for Detection of Herpes Simplex Virus DNA (2004) (34)
- The UL14 Tegument Protein of Herpes Simplex Virus Type 1 Is Required for Efficient Nuclear Transport of the Alpha Transinducing Factor VP16 and Viral Capsids (2007) (34)
- Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models (2013) (33)
- Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases (2019) (33)
- Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. (2020) (33)
- Diagnosis of childhood BK virus cystitis by electron microscopy and PCR. (1993) (33)
- Detection and direct typing of herpes simplex virus by polymerase chain reaction (2004) (32)
- Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production (2017) (32)
- Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice (2011) (32)
- Ultralente insulin treatment of transient neonatal diabetes mellitus. (1996) (31)
- Comparison of quantitations of viral load in varicella and zoster. (2000) (31)
- Evaluation of systemic inflammatory responses in neonates with herpes simplex virus infection. (2004) (31)
- Successful treatment of neonatal herpes simplex-type 1 infection complicated by hemophagocytic lymphohistiocytosis and acute liver failure. (2008) (31)
- Monitoring of Active HHV‐6 Infection in Bone Marrow Transplant Recipients by Real Time PCR; Comparison to Detection of Viral DNA in Plasma by Qualitative PCR (2002) (31)
- Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan (2003) (30)
- Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening. (2015) (30)
- Viral Load in Epstein‐Barr Virus‐Associated Hemophagocytic Syndrome (2002) (30)
- Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells (2016) (30)
- Association of transforming growth factor-β1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases (2007) (30)
- Quantitation of cytomegalovirus DNA in lung tissue of bone marrow transplant recipients. (1992) (29)
- EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS (2013) (29)
- Investigation of Varicella‐Zoster Virus DNA in Lymphocyte Subpopulations by Quantitative PCR Assay (2001) (29)
- Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection. (2006) (29)
- Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting (2019) (29)
- Rapid detection of herpes simplex virus DNA in cerebrospinal fluid: comparison between loop-mediated isothermal amplification and real-time PCR (2005) (28)
- Combination therapy with intraventricular interferon-α and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay (2003) (28)
- Virological aspects of Epstein-Barr virus infections. (2005) (27)
- Relapse of neonatal herpes simplex virus infection (2003) (27)
- Antitumor activities of valproic acid on Epstein–Barr virus‐associated T and natural killer lymphoma cells (2012) (27)
- Comparison of Quantitations of Viral Load in Varicella and Zoster (2000) (26)
- Association of Cytomegalovirus with Infantile Hepatitis (2005) (26)
- Polymerase chain reaction-proved herpes simplex encephalitis in children. (1998) (26)
- Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation (2021) (26)
- Quantitative Analysis of Herpesvirus Load in the Lymph Nodes of Patients With Histiocytic Necrotizing Lymphadenitis Using a Real-Time PCR Assay (2006) (25)
- Herpes simplex virus type 2 tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role in transport and/or release of virions (2009) (25)
- Flow cytometric analysis of cytomegalovirus‐specific cell‐mediated immunity in the congenital infection (2003) (25)
- Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease. (2016) (24)
- Anti-CCR4 Monoclonal Antibody Mogamulizumab for the Treatment of EBV-Associated T- and NK-Cell Lymphoproliferative Diseases (2014) (24)
- Reactivation of persistent Epstein–Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface (2015) (24)
- BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection (2018) (23)
- Multiplex Real-Time PCR Assay for Simultaneous Quantification of BK Polyomavirus, JC Polyomavirus, and Adenovirus DNA (2010) (23)
- Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch (2010) (23)
- Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus type 1 infection in a closed community. (1992) (22)
- The Epstein-Barr Virus BDLF4 Gene Is Required for Efficient Expression of Viral Late Lytic Genes (2015) (22)
- Minus strand RNA of hepatitis C virus in liver tissues. (1991) (21)
- Varicella exposure in a neonatal medical centre: successful prophylaxis with oral acyclovir. (2003) (21)
- Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells (2018) (20)
- Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury (2011) (20)
- Clinical manifestations of primary herpes simplex virus type 1 infection in a closed community. (1991) (20)
- Epstein–Barr virus‐specific T‐cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation (2002) (20)
- Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders. (2005) (20)
- Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. (2010) (19)
- S-Like-Phase Cyclin-Dependent Kinases Stabilize the Epstein-Barr Virus BDLF4 Protein To Temporally Control Late Gene Transcription (2019) (19)
- The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas (2015) (19)
- Cytomegalovirus and Epstein–Barr virus coinfection in three toddlers with prolonged illnesses (2009) (18)
- Vidarabine Therapy for Severe Chronic Active Epstein–Barr Virus Infection (2001) (18)
- Epstein‐Barr virus (EBV)‐associated post‐transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation (2003) (18)
- Herpes simplex virus induces extensive modification and dynamic relocalisation of the nuclear mitotic apparatus (NuMA) protein in interphase cells (2008) (17)
- Chronic administration of DSP‐7238, a novel, potent, specific and substrate‐selective DPP IV inhibitor, improves glycaemic control and β‐cell damage in diabetic mice (2010) (17)
- The prevalence of TT virus (TTV) infection and its relationship to hepatitis in children (1999) (17)
- Clinicoepidemiologic Status of Mother-To-Child Infections: A Nationwide Survey in Japan (2013) (17)
- Risk factors for poor outcome in congenital cytomegalovirus infection and neonatal herpes on the basis of a nationwide survey in Japan (2013) (16)
- Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons (2011) (16)
- Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection. (2008) (16)
- Fatal adult case of severe lymphocytopenia associated with reactivation of human herpesvirus 6 (2002) (16)
- EBV-associated T and NK cell lymphoproliferative disorders: consensus report of the 4th Asian Hematopathology Workshop (2012) (16)
- Recent epidemiologic trends in alveolar echinococcosis prevalence in humans and animals in Hokkaido. (1999) (16)
- Application of flow cytometric in situ hybridization assay to Epstein–Barr virus‐associated T/natural killer cell lymphoproliferative diseases (2012) (15)
- Monitoring herpesvirus DNA in three cases of acute retinal necrosis by real-time PCR. (2004) (15)
- Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes (2019) (15)
- Multicenter evaluation of prototype real‐time PCR assays for Epstein‐Barr virus and cytomegalovirus DNA in whole blood samples from transplant recipients (2010) (15)
- Fatal varicella infection in a girl with systemic lupus erythematosus after oral acyclovir prophylaxis (2006) (15)
- Presence of Epstein–Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves’ disease patients and in healthy individuals (2014) (15)
- HSV-2–related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS (2016) (15)
- Herpes simplex virus type 1 UL14 tegument protein regulates intracellular compartmentalization of major tegument protein VP16 (2011) (15)
- Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2 (2012) (15)
- Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein–Barr virus-associated T cell and natural killer cell lymphoma (2014) (15)
- Prospective monitoring of Epstein–Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab (2012) (15)
- Demonstration of type II latency in T lymphocytes of Epstein–Barr Virus‐associated hemophagocytic lymphohistiocytosis (2013) (15)
- Hepatitis C viral sequences in sera during the acute phase of infection. (1990) (14)
- Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis. (2011) (14)
- Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. (2011) (14)
- The Epstein-Barr virus BRRF2 gene product is involved in viral progeny production. (2015) (14)
- Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation (2014) (14)
- Evaluation of apoptosis in Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis (2006) (13)
- Oncolytic activity of HF10 in head and neck squamous cell carcinomas (2019) (13)
- Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection (2020) (13)
- Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report. (2013) (13)
- Elevated expression of activation-induced cytidine deaminase in T and NK cells from patients with chronic active Epstein-Barr virus infection. (2011) (13)
- Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein–Barr virus infection (2006) (13)
- Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells (2017) (13)
- Absence of associations between influenza-associated encephalopathy and human herpesvirus 6 or human herpesvirus 7 (2003) (12)
- Relationship between lower respiratory tract infections caused by respiratory syncytial virus and subsequent development of asthma in Japanese children. (2011) (12)
- The first reported case of a dog infected with Echinococcus multilocularis in Saitama prefecture, Japan. (2006) (12)
- Generation and Characterization of UL21-Null Herpes Simplex Virus Type 1 (2012) (12)
- Replication‐competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment (2007) (12)
- Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection (1995) (12)
- Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor (2016) (12)
- A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis (2015) (11)
- Baculovirus expression, purification, and properties of varicella-zoster virus gE, gI, and the complex they form. (1998) (11)
- Initial Characterization of the Epstein–Barr Virus BSRF1 Gene Product (2019) (11)
- RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells. (2021) (11)
- Detection of cytomegalovirus DNA in preserved umbilical cords from patients with sensorineural hearing loss (2009) (11)
- Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells. (2015) (11)
- A case of Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis with severe cardiac complications (2016) (11)
- Increased T-cell responses to Epstein–Barr virus with high viral load in patients with Epstein–Barr virus-positive diffuse large B-cell lymphoma (2015) (10)
- Unrelated bone marrow transplantation induced long-term remission in a patient with life-threatening Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. (2011) (10)
- Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level (2002) (9)
- Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma (2021) (9)
- CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphoma. (1999) (8)
- Diabetic Mice Show an Aggravated Course of Herpes-Simplex Virus–Induced Facial Nerve Paralysis (2012) (8)
- Immunogenicity of inactivated seasonal influenza vaccine in adult and pediatric liver transplant recipients over two seasons (2013) (8)
- Large deletion of the X‐linked lymphoproliferative disease gene detected by fluorescence in situ hybridization (2000) (8)
- The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation (2017) (8)
- Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders (2019) (8)
- [Chronic active Epstein-Barr virus infection]. (2011) (8)
- Herpes simplex virus induces the marked up-regulation of the zinc finger transcriptional factor INSM1, which modulates the expression and localization of the immediate early protein ICP0 (2011) (8)
- The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model. (2017) (8)
- Viral DNA loads in various blood components of patients with Epstein-Barr virus-positive T/NK cell lymphoproliferative diseases. (2019) (7)
- Large deletion of the X-linked lymphoproliferative disease gene detected by fluorescence in situ hybridization. (2000) (7)
- The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production (2017) (7)
- Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells (2018) (7)
- Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity (2019) (7)
- Role of Epstein–Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma (2021) (6)
- Human cytomegalovirus infection during childhood: detection of viral DNA in peripheral blood by means of polymerase chain reaction (2004) (6)
- Replication of Epstein-Barr Virus Primary Infection in Human Tonsil Tissue Explants (2011) (6)
- Identification of Epstein-Barr virus-infected CD27+ memory B-cells in liver or stem cell transplant patients. (2011) (5)
- Diagnostic Testing in Epstein-Barr Virus Infection (2001) (5)
- Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases (2019) (5)
- Causes of vertical transmission of hepatitis B virus under the at‐risk prevention strategy in Japan (2013) (5)
- A case of a long‐time survivor with chronic active Epstein–Barr virus infection (2004) (5)
- The BOLF1 gene is necessary for effective Epstein-Barr viral infectivity. (2019) (5)
- Oligonucleotide Microarray Analysis of (2008) (5)
- Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia (2017) (5)
- Human Herpesvirus 6–Associated Encephalopathy in a Child with Dravet Syndrome (2012) (5)
- Decreasing the Epstein‐Barr virus load by adjusting the FK506 blood level (2002) (5)
- Hepatocellular apoptosis associated with cytotoxic T/natural killer‐cell infiltration in chronic active EBV infection (2009) (5)
- A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma. (2014) (4)
- Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals (2002) (4)
- NK-cell post-transplant lymphoproliferative disease with chronic active Epstein-Barr virus infection-like clinical findings. (2019) (4)
- [Herpes simplex encephalitis]. (1968) (4)
- Chronic active EBV infection with features of granulomatosis with polyangiitis (2016) (4)
- Remission of juvenile idiopathic arthritis with primary Epstein-Barr virus infection. (2013) (4)
- EBV genome variations enhance clinicopathological features of nasopharyngeal carcinoma in a non‐endemic region (2022) (4)
- Pretreatment EBV-DNA Copy Number Is Predictive for Response to SMILE Chemotherapy for Newly-Diagnosed Stage IV, Relapsed or Refractory Extranodal NK/T-Cell Lymphoma, Nasal Type: Results of NKTSG Phase II Study (2010) (4)
- Chronic active Epstein–Barr virus infection with dilatation of the Valsalva sinus (2006) (4)
- Interleukin‐17A‐producing T lymphocytes in chronic active Epstein–Barr virus infection (2013) (4)
- Genetic Background of Chronic Active Epstein-Barr Virus Disease (2017) (4)
- Acute retinal necrosis caused by herpes simplex virus type 2 in a 3-year-old Japanese boy (2009) (3)
- Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders. (2003) (3)
- EPSTEIN–BARR VIRUS (EBV)-ASSOCIATED T/NK LYMPHOPROLIFERATIVE DISEASES IN NON-IMMUNOCOMPROMISED HOSTS: PROSPECTIVE ANALYSIS OF 108 CASES (2011) (3)
- Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma (2020) (3)
- Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days (2020) (3)
- EBV Exploits RNA m6A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle (2022) (3)
- Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter (2017) (3)
- A STING inhibitor suppresses EBV‐induced B cell transformation and lymphomagenesis (2021) (3)
- Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus 1 infection (1990) (3)
- A systemic form of chronic active Epstein-Barr virus infection diagnosed from erythema nodosum-like skin lesions (2020) (2)
- Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection (2022) (2)
- The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines (2022) (2)
- Simultaneous Quantification of Epstein-Barr Virus, Cytomegalovirus, and Human Herpesvirus 6 DNA in Samples from Transplant Recipients by Multiplex Real-Time PCR Assay (cid:1) (2007) (2)
- [EBV-positive T/NK lymphoproliferative disease in childhood]. (2012) (2)
- [Clinical features of adult-onset chronic active Epstein-Barr virus infection]. (2019) (2)
- T‐cell receptor Vα region usage in the cerebrospinal fluid of patients with mumps meningitis (1993) (2)
- Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy (2019) (2)
- [Chronic active EBV infection]. (2006) (1)
- Induction of Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 1 ( LMP 1 ) by Transcription Factors Activating Protein 2 ( AP-2 ) and Early B 2 Cell Factor ( EBF ) (2016) (1)
- PD-L1 upregulation by lytic induction of Epstein-Barr Virus. (2022) (1)
- Chronological Changes in Epstein-Barr Virus Genome and Subsets of Peripheral Mononuclear Cells in a Case of HLH (2011) (1)
- [Mother-to-infant transmission of HSV]. (2007) (1)
- [Herpes simplex encephalitis in childhood]. (2006) (1)
- JAK inhibitors for refractory lymphoma (2018) (1)
- Increased Peripheral T Cell Responses to EBV-Infected Cells with Frequent Detection of EBV-DNA In Plasma and Viral mRNA In Peripheral B-Cells In Immunocompetent EBV-Positive Diffuse Large B-Cell Lymphoma Patients (2010) (1)
- A pediatric case of hepatitis B virus subgenotype A2 in Japan (2013) (1)
- Infection-Activated T Cells in Primary EBV + of CD 8 Antigen-Driven Expansion and Contraction (1999) (1)
- A Case of Hypersensitivity Syndrome due to Phenobarbital with Another Hyperreaction of Ticlopidine Hydrochloride-Including the follow-up Findings of the HHV-6 IgG Titer during a One-year Period- (2003) (0)
- ADULT PATIENTS WITH CAEBV‐LIKE FEATURES: A DISTINCT SUBTYPE OF EPSTEIN‐BARR VIRUS POSITIVE T/NK‐CELL LYMPHOPROLIFERATIVE DISORDER (2017) (0)
- The Presence of Defective Epstein-Barr Virus (EBV) Infection in Patients with EBV-Associated Hematological Malignancy (2018) (0)
- Mutational analysis of SAP/SH2D1A gene in chronic active Epstein-Barr virus infection (2001) (0)
- N6-methyladenosine Modification of Hepatitis B Virus RNA in the Coding Region of HBx (2023) (0)
- A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies (2018) (0)
- [An allogeneic bone marrow transplantation for chronic myelocytic leukemia with a large extramedullary tumor in the pelvic cavity]. (1996) (0)
- [Treatment of neonatal herpes]. (2006) (0)
- T-cell receptor V alpha region usage in the cerebrospinal fluid of patients with mumps meningitis. (1993) (0)
- Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis (2022) (0)
- Comprehensive Analyses of Intraviral Epstein-Barr Virus Protein–Protein Interactions Hint Central Role of BLRF2 in the Tegument Network (2022) (0)
- Supplementary Figure: Ganciclovir Therapy for Congenital Cytomegalovirus Infection in Six Infants (2005) (0)
- Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producer cells assists de novo infection (2020) (0)
- The 100th anniversary of the Nagoya Journal of Medical Science: a message from the Dean (2023) (0)
- Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection (2022) (0)
- Elderly‐onset systemic Epstein–Barr virus‐positive T‐cell lymphoma of childhood (2022) (0)
- Studies on sugar metabolism in the liver diseases Reinvestigation of galactose tolerance by gas-liquid chromatography (1971) (0)
- Cancer Therapy: Preclinical mTOR Inhibitors Induce Cell Cycle Arrest and Inhibit Tumor Growth in Epstein-Barr Virus-Associated T and Natural Killer Cell Lymphoma Cells (2014) (0)
- [Diagnosis of herpesvirus infection]. (2006) (0)
- Short Communication Identification of Epstein-Barr virus-infected CD27 + memory B-cells in liver or stem cell transplant patients (2011) (0)
- 1792. Viral DNA Loads in Various Blood Components of Patients with EBV-Positive T/NK Cell Lymphoproliferative Diseases (2019) (0)
- Autumn meeting of the cryogenic association of Japan Sendai, Japan, 9–11 November 1983 (1985) (0)
- A Case of Helicobacter cinaedi Bacteremia which Determined Antibiotics Treatment Duration after Negative Surveillance Blood Culture in a Hemodialysis Patient (2019) (0)
- Epidemiological Investigation of Adult Varicella in Five Foreign Workers (2022) (0)
- [Prevention, diagnosis, and treatment of viral infections in patients with hematologic diseases]. (2007) (0)
- Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection. (2023) (0)
- Publisher Correction: Defective Epstein–Barr virus in chronic active infection and haematological malignancy (2019) (0)
- A Case of Necrotising Soft-tissue Infection and Sepsis Caused by Shewanella haliotis (2018) (0)
- IS8-1CURRENT UNDERSTANDING OF THE ROLE OF EPSTEIN-BARR VIRUS IN LYMPHOMAGENESIS (2014) (0)
- [Laboratory diagnosis of protozoan and parasitic diseases. 2. Helminthiasis. c. Echinococcosis]. (1998) (0)
- Serumamyloid A protein inacuteviral infections (1993) (0)
- A HIGH-THROUGHPUT ANTIBODY SCREENING PLATFORM TOWARD EMBRYOLOGY (2014) (0)
- In Silico Analysis and Synthesis of Nafamostat Derivatives and Evaluation of Their Anti-SARS-CoV-2 Activity (2022) (0)
- A Comprehensive, Multiomics Analysis of Natural Killer-Cell Malignancies (2022) (0)
- Short title Vasohibin family in the regulation of angiogenesis (2016) (0)
- Vasohibin, a VEGF-inducible endothelium-derived angiogenesis inhibitor, may act as a terminator of angiogenesis (2006) (0)
- Multiplex Real-Time PCR Assay for Simultaneous Quantification of BK Polyomavirus, JC Polyomavirus, and Adenovirus DNA (cid:1) (2010) (0)
- [Paul-Bunnell test, Davidsohn differential test, mono-spot test]. (2010) (0)
- [EBV and Lymphomagenesis]. (2019) (0)
- Defective Epstein–Barr virus in chronic active infection and haematological malignancy (2019) (0)
- [Epstein-Barr virus and hematological neoplasms]. (2012) (0)
- A monoclonal expansion of Epstein-Barr virus-infected natural killer cells after allogeneic peripheral blood stem cell transplantation. (2013) (0)
- The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation (2017) (0)
- Evaluation and Nutritional Support in Critically Ill Infants (1997) (0)
- Cover Image (2005) (0)
- Prolonged presence of viral DNA in serum and CSF in neonatal herpes simplex virus infections (1996) (0)
- [Progress in the management of cytomegalovirus(CMV) infection]. (1998) (0)
- Chronic active EB virus infection (2021) (0)
- An X-linked lymphoproliferative disease (XLP) patient with uneventful primary infection and fatal reactivation with Epstein-Barr virus (EBV) (2002) (0)
- Modes of infection Epstein – Barr virus Reviews in Medical Virology (2014) (0)
- C-Terminal-Truncating ASXL1 Mutations Induce MDS Via Inhibition Of PRC2 (2013) (0)
- [Prophylaxis and treatment of alpha herpesvirus infection--vaccine]. (2000) (0)
- EBV-associated NK and T-cell lymphoid neoplasms (2022) (0)
- Recent advances in research on chronic active EB virus infection. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hiroshi Kimura?
Hiroshi Kimura is affiliated with the following schools:
